Pendulum Therapeutics

Join Sharon H., MD, Chief Medical Officer for IntellxxDNA®, and Christina O'Connor, RD, for a fascinating discussion on the potential of next-generation probiotics. Learn how Akkermansia muciniphila and Clostridium butyricum may play a role in supporting overall health, potentially modulating the effects of specific genetic variations linked to: Diabetes, obesity, inflammatory conditions, and autoimmune disorders. This session will explore the future of personalized gut health solutions and their potential impact on managing complex conditions. Register now: https://shorturl.at/NTm5g

You’re invited to unlock the secrets of the gut microbiome at our sponsored lunch at #IFMAIC2024 on May 31st. Pendulum Co-Founder & CEO Colleen Cutcliffe, will be joined by award-winning actor and Pendulum Chief Communications Officer, Halle Berry, and Dr. Kara Fitzgerald ND, IFMCP, to discuss how Akkermansia and other next-generation strains optimize the power of the gut microbiome to improve metabolic health.

Join us for the next installment of our Spring Speaker Series featuring Julie Greenberg, ND, RH(AHG), MBA discussing the research linking the gut microbiome and chronic dermatological issues, the role Akkermansia muciniphila plays in the gut/skin axis, and case studies demonstrating the effective treatment of acne by addressing the gut microbiome. Register now: https://shorturl.at/O1MIT

Join microbiome and diabetes expert, Orville Kolterman, MD, and summit host Dr. Beverly Yates, ND  for an in-depth interview on how the microbiome influences glucose management. - The pathophysiological changes that occur in the gut microbiome linking gut health and metabolic syndrome - The beneficial functions of certain gut bacterial strains that may be deficient in people with type 2 diabetes - The mechanisms through which probiotic strains such as A. muciniphila and C. butyricum induce downstream GLP-1 production - The science and evidence for the use of a synbiotic formulated to improve gut health and assist with glycemic management in people with type 2 diabetes Register now: https://shorturl.at/tzHRT

See you at A4M Spring Congress in West Palm Beach, Florida for our two info-packed sessions with Adam Perlman, MD, MPH and Erik J. Modlo MD, MBA, IMFCP!

See you at A4M Spring Congress in West Palm Beach, Florida for our two info-packed sessions with Adam Perlman, MD, MPH and Erik J. Modlo MD, MBA, IMFCP!

GLP-1 products and optimizing endogenous GLP-1 hormone production play a crucial role in patient care today. Join experts Darshan Shah, MD and Ashley Koff RD in our continuing spring speaker series for a live discussion about how healthcare providers evaluate and personalize GLP-1 recommendations for patients. Topics will include screening techniques, labs, supplements, nutrition advice, and efficient business models for improved patient outcomes. Register now: https://zip.lu/3iqGB

Join industry experts, including Colleen Cutcliffe, Pendulum Co-Founder & CEO, Peter Attia, MD, host of The Drive podcast, and Sara Gottfried, MD, New York Times bestselling author, as they offer in-depth cardiometabolic knowledge, focusing on natural and complementary GLP-1 therapies. Register now: https://rb.gy/yuzslt

Proud doesn’t even begin to describe how we feel about our powerhouse CEO, Colleen Cutcliffe, PhD, who has been recognized on Inc.’s Female Founders 250 list for 2024! Colleen’s commitment to innovating microbiome science is truly inspirational. Thank you Colleen Cutcliffe for your leadership, and thanks to Inc. Magazine for the honor! https://lnkd.in/d_2CzDy #FemaleFounders #entrepreneurs #probiotics #microbiome #womeninstem #womenintech

Join Colleen Cutcliffe, Co-Founder and CEO of Pendulum, in collaboration with the The American Academy of Anti-Aging Medicine (A4M), to learn about the latest research on the impact of Akkermansia and other novel strains on GLP-1 signaling, satiety, cravings, and how to leverage these probiotics for metabolic disorders. Register now: https://rb.gy/cimm1x